Carey Danis & Lowe Investigates Bard LifeStent Cases After FDA Class 1 Recall

A national law firm representing defective medical device victims, Carey Danis & Lowe is currently investigating Bard LifeStent cases following an FDA class 1 recall.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
Carey Danis & Lowe | Bard LifeStent Recall

Carey Danis & Lowe | Bard LifeStent Recall

Carey Danis & Lowe is currently investigating Bard LifeStent cases, and invites individuals who believe their injuries stem from defective stent deployment to reach out to the law firm for a gratis legal evaluation.

St. Louis, Missouri (PRWEB) October 30, 2013

The defective medical device attorneys at Carey Danis & Lowe are currently investigating Bard LifeStent cases following an October 18, 2013 recall announcement made by the U.S. Food and Drug Administration (FDA). As a national law firm representing victims of defective medical devices, Carey Danis & Lowe provides legal assistance to individuals who have experienced injuries from faulty medical products that have been recalled by the FDA.

In mid-October, the FDA announced a class 1 recall of the Bard LifeStent Solo Vascular Stent over faulty deployment.* The Bard LifeStent, a mesh tube implanted into a blood vessel to treat lesions, is known to deploy partially and with difficulty, and in some cases, the stent entirely fails to deploy.

These deployment problems place patient health and safety at risk. According to the FDA, patients with inadequately deployed Bard LifeStent devices have experienced bleeding, limb loss, heart attacks, stroke, and death. Furthermore, patients have often undergone surgical operations to repair and replace the defective stent to avoid future health complications.

Though the FDA has taken action to recall the Bard LifeStent device due to life-threatening adverse events, claims targeted at Bard's medical device have not yet been heard in a court of law at the time of writing.

The FDA class 1 recall concerns stents manufactured by Bard between November 2011 to June 2012.

Carey Danis & Lowe is currently investigating Bard LifeStent cases, and invites individuals who believe their injuries stem from defective stent deployment to reach out to the law firm for a gratis legal evaluation. For more information about legal services provided by Carey Danis & Lowe, call 800-721-2519.

---

About Carey Danis & Lowe

Carey Danis & Lowe is a plaintiff's litigation firm based in St. Louis, Missouri with law offices across the United States in Illinois, Missouri, and Florida. Carey Danis & Lowe specializes in defective drug and pharmaceutical litigation and class action lawsuits. The Carey Danis & Lowe team is comprised of experienced attorneys working alongside knowledgeable and professional staff that includes medical doctors, nurses, and information technology specialists. Contact Carey Danis & Lowe at 800-721-2519 for more information about our legal services.

Source
*U.S. Food and Drug Administration, Bard LifeStent Solo Vascular Stent: Class 1 Recall – Failure to Deploy: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm371415.htm


Contact